Alloy Personal Training Business The GLP-1 Effect: Game Changer or Industry Threat?
In this episode, Rick speaks with Alloy COO Suzanne Robb about whether weight loss shots are a friend or foe of the fitness industry.
Suzanne revisits her experience with GLP-1 weight loss medications - semaglutide and tirzepatide. She offers a unique perspective on how medical intervention doesn't have to conflict with a fitness-first lifestyle.
Suzanne also opens up about her struggles with weight loss in her 60s despite years of working out and healthy eating. When traditional methods failed, she turned to GLP-1s and found success, losing 30 pounds and regaining control of her health.
She details her journey, the pros and cons of different medications, and how strength training preserved her muscle mass.
Rick and Suzanne explain how Alloy’s strength-based approach makes it the perfect companion to these medications. They bust myths, challenge fitness dogma, and offer a hopeful message for those feeling stuck.
Listen in to learn more about how to align your fitness business with medical wellness.
Key Takeaways
Intro (00:00)
Semaglutide and tirzepatide as weight loss aids (02:25)
Weight loss results and side effects after 3 months (09:05)
Transition to maintenance dosing (12:02)
Criticism from fitness purists (14:23)
Benefits of GLP-1s beyond just weight loss (16:27)
Strength training’s role in preventing muscle loss (20:08)
GLP-1s shift calorie focus from burning to managing intake (24:03)
Alloy and GLP-1s are not competitors - they’re allies (30:42)
Additional Resources:
- Learn About The Alloy Franchise Opportunity
---------
You can find the podcast on Apple, Google, Spotify, Stitcher, or wherever you listen to podcasts.
If you haven’t already, please rate and review the podcast on Apple Podcasts!